Complex PUO Analysis — 30-year-old Female

CT Abdomen/Pelvis — Key Findings (Report Summary)

• Large multiloculated complex cystic pelvic mass ~16.5 × 13.4 × 18 cm — bilateral iliac fossa extension, variably enhancing solid component, focal wall nodularity in left posterolateral aspect, bilateral ovaries not separately visualized
• Hepatomegaly (~17 cm)
• Mild right hydroureteronephrosis (mass effect)
• Mild ascites
• Retroperitoneal lymphadenopathy — elongated nodes up to ~1.4 cm
• Multiple sclerotic + lytic foci in mid/lower thoracic and lumbar vertebrae — ?significance
• Focal abutment on rectum
• Uterus displaced rightward

Diagnostic Framework — Two Parallel Pathologies

Diagnosis 1: Scrub Typhus (Rickettsial Infection)

• OXK (Weil-Felix) titre ≥ 1:320 — strongly positive (diagnostic threshold for scrub typhus is ≥1:160; ≥1:320 is highly significant)
• Fever with high TC
• High CRP (130) but relatively low ESR (20) — this pattern (acute phase reactant dissociation) is characteristic of rickettsial infections
• Already on doxycycline (appropriate first-line agent) — Day 5, still spiking

1. Doxycycline resistance / attenuated response — documented especially in Southeast Asia/India (Thailand strains), and increasingly in Indian subcontinent
2. Inadequate dosing — dose should be 200 mg/day (100 mg BD) IV/oral; confirm this
3. Coexisting confounding source of fever — the large pelvic mass/endometrioma/possible TOA is an independent fever driver
4. Severe scrub typhus with organopathy — hepatomegaly supports this; rickettsial vasculitis can cause prolonged fever

Diagnosis 2: Large Pelvic Complex Mass — Endometrioma vs. Malignancy

Further Evaluation Needed

For Rickettsial / Infectious Workup

1. IFA (Indirect Fluorescent Antibody) for Orientia tsutsugamushi — gold standard; Weil-Felix OXK is a screening test only (sensitivity ~50–75%, specificity limited); confirm with IFA serology (paired titres: acute + convalescent 2 weeks apart showing ≥4-fold rise)
2. PCR for Orientia tsutsugamushi from blood / eschar biopsy — most sensitive in first week of illness
3. Eschar search — thorough skin exam (groins, axillae, hairline, perineum); present in 50–80% of scrub typhus cases; finding an eschar is pathognomonic
4. Blood cultures — rule out concurrent bacteremia (the large pelvic mass could have become infected; piperacillin-tazobactam is broad-spectrum and appropriate for that)
5. LFTs + Bilirubin — scrub typhus causes hepatitis; high aminotransferases expected
6. Procalcitonin — helps distinguish bacterial from rickettsial/viral fever if intermediate
7. Dengue serology (NS1, IgM/IgG) — co-infection possible in endemic region, can cause persistent fever
8. Leptospira IgM ELISA / MAT — fever with hepatomegaly in India; important differential
9. Malaria smear + RDT — mandatory in any Indian PUO

For Pelvic Mass

1. MRI Pelvis with contrast — recommended by the radiologist ("SOS MRI correlation"); superior to CECT for characterising ovarian masses, solid components, capsule integrity, peritoneal implants
2. CA 19-9, CEA, HE4, LDH — complete tumour marker panel for ovarian pathology
3. ROMA score (Risk of Ovarian Malignancy Algorithm) using CA-125 + HE4
4. Gynaecology-Oncology consultation — urgent; mass is 18 cm with solid components and nodes; surgical planning required
5. Bone scan or PET-CT — for the vertebral lytic/sclerotic lesions; if malignancy confirmed, this is staging
6. FNAC/biopsy of retroperitoneal node if accessible — tissue diagnosis
7. Endoscopy (colonoscopy) — if rectal abutment symptoms present; CT shows focal rectal contact

Treatment Plan

For Persistent Fever / Rickettsial Disease

• For severe scrub typhus with persistent fever at Day 5:
  • Option A: Add Azithromycin to Doxycycline — combination shown to reduce composite poor outcomes (33% vs 47–48% with monotherapy) in the MORU severe scrub typhus trial
  • Azithromycin: 500 mg IV/oral OD × 3–5 days
  • Azithromycin has superior intracellular penetration; doxycycline acts faster on extracellular bacteria; combination covers both compartments
• Option B: Switch to Azithromycin if doxycycline resistance suspected (especially with Indian/South Asian strains)

• Must be 100 mg BD (200 mg/day) IV or oral — not 100 mg OD

• The large pelvic mass could be infected endometrioma / tubo-ovarian abscess contributing to ongoing fever — piperacillin-tazobactam covers this (continue)
• If mass is infected, surgical drainage may be needed after oncological assessment

Regarding the Mass

• Do NOT rush to surgery while active rickettsial infection is ongoing — risk of complications
• Treat infection first, then proceed with elective/semi-elective gynae-oncology evaluation
• However, if the mass is felt to be an infected TOA causing fever independently, drainage (laparoscopic or IR-guided) may be needed

Summary Table

Key Clinical Pearl

References: Harrison's Principles of Internal Medicine 22e (Chap. 192 Rickettsial Diseases) | Sherris & Ryan's Medical Microbiology 8e | PMID: 38110855 (meta-analysis doxy vs azithromycin scrub typhus) | PMID: 37407239 (combination therapy severe scrub typhus)

Clinical Reappraisal: Dual-Agent Treatment Failure

What This Means

Immediate Action Plan

Step 1 — Urgently Revisit the Diagnosis

• Infected endometrioma / tubo-ovarian abscess (TOA) — fever is from pelvic sepsis, not rickettsial
• Ovarian malignancy with peritoneal involvement — tumour fever (IL-6/IL-1 driven), not antibiotic-responsive
• Ruptured/leaking endometrioma causing chemical peritonitis

Step 2 — Escalate Investigations Now

Step 3 — The Pelvic Mass Needs Urgent Characterisation

• MRI Pelvis with contrast — cannot defer further; critical to determine if this is an infected TOA, endometrioma, or malignancy
• Tumour markers: CA-125 (already done = 150), add HE4, CA 19-9, CEA, LDH, AFP (AFP + LDH for germ cell tumour given her young age — 30yr)
• Gynae-Oncology consultation today
• If TOA is confirmed — surgical drainage (laparoscopic or ultrasound-guided aspiration) is therapeutic and removes the fever source; antibiotics alone often fail TOA >8 cm

Step 4 — If Scrub Typhus Still Suspected Despite Failure

• Rifampicin 600–900 mg/day orally × 7 days
• Evidence from Watt et al. (Lancet 2000) and multiple Indian case series: rifampicin is active against doxycycline-resistant Orientia tsutsugamushi
• Mechanism: RNA polymerase inhibition — different target from tetracyclines/macrolides
• Used successfully in Southeast Asia where doxycycline resistance is documented
• Can be used as monotherapy or combined with doxycycline (doxycycline + rifampicin combination shown active in vitro)

Note: Rifampicin is an enzyme inducer — check drug interactions, and it turns urine/secretions orange (warn patient)

Diagnostic Hierarchy Summary

Persistent fever despite Doxy (100BD) + Azithromycin × 5 days
            |
    ┌───────┴────────┐
    ↓                ↓
Scrub typhus      Fever from pelvic 
still active?     mass (TOA / malignancy)?
    |                ↓
IFA + PCR       MRI pelvis + 
blood cultures   Gynae-Onco consult
    |                ↓
Rifampicin       Drain if TOA
600-900mg/d      Chemo/Surgery if malignancy

The Vertebral Lytic Lesions — Must Not Be Ignored

Practical Bottom Line

1. Stop chasing rickettsial disease blindly — both standard agents have been given for 5 days and failed
2. The pelvic mass is now the leading diagnosis for fever — it needs definitive characterisation urgently
3. Add Rifampicin only if IFA/PCR confirms active rickettsial disease and other sources are excluded
4. Piperacillin-tazobactam should continue — it covers the infected mass/TOA component
5. Urgent MRI pelvis + Gynae-Oncology review today — the clinical picture is evolving towards a malignancy workup, not an extended antibiotic course

How a Ruptured/Leaking Endometrioma Causes Fever

The Core Mechanism: Chemical Peritonitis

• Persistent spiking fever — prostaglandin and cytokine-mediated, not bacterial
• High CRP with relatively low ESR (exactly as seen in this patient — CRP 130, ESR 20)
• Adhesion formation — peritoneum responds to the chronic irritant by laying down fibrin → dense adhesions
• No response to antibiotics — because the fever is chemical/inflammatory, not infective

This Explains EVERYTHING in This Case

The Critical Insight: CRP 130 + ESR 20

• Rickettsial disease, OR
• Chemical/sterile peritonitis (endometrioma leak)
• NOT typical bacterial infection (which raises both together)

Now What? Post-Operative Management

1. Thorough Peritoneal Washout (if not already done)

• Copious saline irrigation is mandatory — removes the chocolate fluid that is the source of chemical peritonitis
• Every drop of chocolate fluid left in the pelvis/abdomen will continue to drive fever and adhesion formation
• This alone may resolve the fever within 24–48 hours

2. Complete Cystectomy

• The opened chocolate cyst wall must be excised — leaving endometriotic epithelium behind means continued prostaglandin and cytokine production
• If not already done, cystectomy (ovarian cyst wall excision) is the definitive treatment

3. Adhesiolysis

• Dense adhesions found → careful lysis is needed to restore anatomy and prevent bowel/ureter obstruction

4. Post-Operative Fever Monitoring

• Expect fever to fall within 48–72 hours of adequate surgical clearance and peritoneal wash
• If fever persists beyond 72 hours post-op: then consider:
  • Surgical site infection / residual collection
  • Pelvic abscess (send peritoneal fluid for culture if collected intra-op)
  • Then reconsider rickettsial disease — continue/complete doxycycline course

5. Post-Op Medical Management

• NSAIDs (if no contraindication) — directly block prostaglandin synthesis; very effective for endometriosis-related fever
• Continue pip-tazo perioperatively (covers any secondary contamination from the opened cyst)
• Hormonal suppression post-operatively: GnRH agonist (leuprolide) or combined OCP to prevent recurrence — start after recovery
• Send cyst wall for HPE — the solid component + CA-125 of 150 still needs histology to confirm benign nature and definitively exclude endometrioid carcinoma

6. Reassess the Vertebral Lesions

Bottom Line

Discharge Plan

Medications to Send Home With

Hormonal Suppression — Start After 4–6 Weeks (Once Healed)

• Combined Oral Contraceptive Pill (COCP) — first-line, affordable, continuous (no pill-free interval to suppress menstruation completely)
• OR Dienogest 2 mg OD — progestogen specifically licensed for endometriosis; superior to COCP for pain, good evidence for recurrence prevention
• OR GnRH agonist (Leuprolide 3.75 mg SC monthly × 3–6 months) — for large/severe disease; discuss with gynae-oncology given the size and adhesions

Pending Results — Must Be Followed Up

Discharge Advice to Patient

1. Fever, severe pain, or vomiting → return to ER immediately (secondary peritonitis / abscess)
2. Avoid tampons, intercourse for 4–6 weeks (post-surgical pelvic healing)
3. Follow-up with gynaecologist in 2 weeks — review HPE, initiate hormonal therapy
4. CA-125 to be rechecked in 3 months — should fall significantly after cystectomy; persistent elevation would require further investigation
5. Pelvic physiotherapy referral if significant adhesion-related pain persists
6. Fertility counselling — bilateral involvement and adhesions carry significant fertility risk; if she desires pregnancy in future, early referral to a reproductive medicine specialist

One-Line Summary for Discharge Note